CVR number 39343614
Industry 86.9030 Other human health activities

The Business Psychologist ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  19.0% 16.5% 6.8% 7.9% 7.3%  
Credit score (0-100)  7 10 34 30 32  
Credit rating  B BB BBB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  271 384 335 417 410  
EBITDA  66.0 199 15.5 46.1 33.8  
EBIT  66.0 199 15.5 46.1 33.8  
Pre-tax profit (PTP)  65.9 198.3 16.8 46.3 34.8  
Net earnings  65.9 154.0 11.2 31.9 21.0  
Pre-tax profit without non-rec. items  65.9 198 16.8 46.3 34.8  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -7.5 146 57.5 89.3 110  
Interest-bearing liabilities  6.1 6.2 0.0 5.5 14.4  
Balance sheet total (assets)  68.0 291 119 185 219  
Net Debt  -22.9 -156 -69.1 -144 -77.1  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  271 384 335 417 410  
Gross profit growth  62.3% 41.6% -12.8% 24.6% -1.6%  
Employees  1 0 0 1 1  
Employee growth %  0.0% -100.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  68 291 119 185 219  
Balance sheet change%  12.6% 328.0% -59.0% 55.0% 18.6%  
Added value  66.0 198.8 15.5 46.1 33.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  24.4% 51.8% 4.6% 11.1% 8.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  63.1% 108.5% 8.2% 30.5% 17.2%  
ROI %  234.9% 250.4% 15.9% 60.9% 31.7%  
ROE %  102.7% 143.6% 11.0% 43.4% 21.0%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  -9.9% 50.4% 48.3% 48.3% 50.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -34.6% -78.4% -446.0% -312.5% -228.3%  
Gearing %  -81.6% 4.2% 0.0% 6.2% 13.1%  
Net interest  0 0 0 0 0  
Financing costs %  0.5% 8.5% 0.0% 2.8% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.8 2.0 1.8 2.2 2.2  
Current Ratio  0.8 2.0 1.8 2.2 2.2  
Cash and cash equivalent  29.0 162.1 69.1 149.7 91.5  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -13.4 140.6 51.6 97.8 118.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  66 0 0 46 34  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  66 0 0 46 34  
EBIT / employee  66 0 0 46 34  
Net earnings / employee  66 0 0 32 21